Page last updated: 2024-11-05

zolpidem and ADDH

zolpidem has been researched along with ADDH in 4 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Research Excerpts

ExcerptRelevanceReference
" Clonidine, melatonin, L-theanine, eszopiclone and guanfacine were well tolerated with mild to moderate adverse events; zolpidem was associated with neuropsychiatric adverse effects."2.55Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment. ( Anand, S; Besag, FMC; Chan, EW; Cortese, S; Tong, H; Wong, ICK, 2017)
"Clonidine reduced insomnia; and melatonin also exhibited a positive response, with reduced sleep latency, higher total sleep time, and higher sleep efficiency."2.49To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder. ( Barrett, JR; Giaroli, G; Tracy, DK, 2013)
"Zolpidem is a sedative-hypnotic drug commonly used to treat sleep disorders."1.51Unexpected effect of Zolpidem in a patient with attention deficit hyperactivity disorder. ( Furuhashi, Y, 2019)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anand, S1
Tong, H1
Besag, FMC1
Chan, EW1
Cortese, S1
Wong, ICK1
Furuhashi, Y1
Barrett, JR1
Tracy, DK1
Giaroli, G1
Blumer, JL1
Findling, RL1
Shih, WJ1
Soubrane, C1
Reed, MD1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Observational Study Investigating the Experience of Patients Undergoing Active Insomnia Clinical Trials[NCT05978271]500 participants (Anticipated)Observational2024-08-31Not yet recruiting
Efficacy, Safety and Tolerability of Zolpidem in the Treatment of Children Aged 6 to 17 Years With ADHD-Associated Insomnia. A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study[NCT00318448]Phase 3201 participants (Actual)Interventional2006-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for zolpidem and ADDH

ArticleYear
Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.
    Paediatric drugs, 2017, Volume: 19, Issue:3

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Eszopiclone; Glutamates; Guanfacine

2017
To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:10

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Glutamates; Humans; Pyr

2013

Trials

1 trial available for zolpidem and ADDH

ArticleYear
Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
    Pediatrics, 2009, Volume: 123, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Human

2009

Other Studies

1 other study available for zolpidem and ADDH

ArticleYear
Unexpected effect of Zolpidem in a patient with attention deficit hyperactivity disorder.
    Asian journal of psychiatry, 2019, Volume: 44

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Feeding and Eating Disorders; Female; Humans;

2019